Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size

Clinical, Histological and Biochemical Characterization of Hyperpigmented Lesion

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by National University Hospital, Singapore
Sponsor:
Information provided by:
National University Hospital, Singapore
ClinicalTrials.gov Identifier:
NCT01136629
First received: June 2, 2010
Last updated: January 26, 2014
Last verified: January 2014
History of Changes
  Purpose

Hypothesis -

The developments of solar lentigine and melasma are due to mutations in keratinocytes that drive the production and transfer of pigment from melanocytes to keratinocytes.


Condition
Lentigo
Melasma

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Clinical, Histological and Biochemical Characterization of Hyperpigmented Lesion.

Further study details as provided by National University Hospital, Singapore:

Primary Outcome Measures:
  • Characterization and classification of lentigines and melasma [ Time Frame: 3 years ] [ Designated as safety issue: No ]

    Characterize and classify lentigines and mealsma from a clinical and physiological point of view. This will better understand the cellular processes leading to the development of lentigines (also referred to as Senile or Solar Lentigo).

    Proper characterization and classification of lentigines and melasma would facilitate the development of models to study and find solutions to treat these lesions.
Estimated Enrollment: 160
Study Start Date: June 2008
Estimated Study Completion Date: May 2015
Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
Subjects with hyper-pigmented spots
Subjects age 21 to 80 year old, who have elected to undergo a plastic surgery will be enrolled. Subjects will be from Chinese, Malay, Indian or Caucasian ancestry. Subjects will be female or male with a hyper-pigmented spots.

  Show Detailed Description

  Eligibility
Ages Eligible for Study:   21 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Subjects age 21 to 80 year old, who have elected to undergo a plastic surgery will be enrolled. Patients will be from Chinese, Malay, Indian or Caucasian ancestry. Patients will be female or male with hyper-pigmented spots.

Criteria

Inclusion Criteria:

  • Solar Lentigines and/or Melasma on facial, or neck areas
  • Ethnic background: Chinese, Malay, Indian, Caucasian
  • Age 21 - 80 years old
  • Ability to provide informed consent

Exclusion Criteria:

  • Pregnant and lactating women
  • Children under the age of 20
  • Neoplasm (past or present) in excised area
  • Patients with communicable disease
  • Immuno-compromised patients
  • Current treatment with an investigational drug
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01136629

Contacts
Contact: Thiam Chye Lim, MD 65-67722022 surlimtc@nus.edu.sg
Contact: Eileen Hing 65-67722276 surhch@nus.edu.sg

Locations
Singapore
National University Hospital, Singapore Recruiting
Singapore, Singapore, 119074
Contact: Thiam Chye Lim, MD    65-67722022    surlimtc@nus.edu.sg   
Contact: Eileen Hing    65-67722276    surhch@nus.edu.sg   
Principal Investigator: Thiam Chye Lim, MD         
Sponsors and Collaborators
National University Hospital, Singapore
Investigators
Principal Investigator: Thiam Chye Lim, MD National University Hospital, Singapore
  More Information

No publications provided

Responsible Party: LIM THIAM CHYE / Professor, National University Hospital, Singapore
ClinicalTrials.gov Identifier: NCT01136629     History of Changes
Other Study ID Numbers: NUHS/SUR-PRAS/2010/4, D / 08 / 175
Study First Received: June 2, 2010
Last Updated: January 26, 2014
Health Authority: Singapore: Domain Specific Review Boards

Keywords provided by National University Hospital, Singapore:
Hyper-pigmented spots
Lentigines
Mealsma
 RNA extraction
Isolation of Keratinocytes
Isolation of Melanocytes

ClinicalTrials.gov processed this record on March 03, 2015